Register

SmallMolecules.com > Supplier: CSNpharm

CSNpharm

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

MRK-016 5mg | ≥98%

CSNpharm

MRK-016 is a functionally selective, inverse agonist at the benzodiazepine site of GABAA α5 receptors.

More Information Supplier Page

MRS 1706 50mg | ≥96%

CSNpharm

MRS 1706 is a potent and selective adenosine A2B receptor inverse agonist with Ki of 1.39 nM.

More Information Supplier Page

MRS 1706 5mg | ≥96%

CSNpharm

MRS 1706 is a potent and selective adenosine A2B receptor inverse agonist with Ki of 1.39 nM.

More Information Supplier Page

MRS 1706 100mg | ≥96%

CSNpharm

MRS 1706 is a potent and selective adenosine A2B receptor inverse agonist with Ki of 1.39 nM.

More Information Supplier Page

MRS 1706 10mg | ≥96%

CSNpharm

MRS 1706 is a potent and selective adenosine A2B receptor inverse agonist with Ki of 1.39 nM.

More Information Supplier Page

MRS 1754 10mg | ≥98%

CSNpharm

MRS 1754 is a selective adenosine A2B receptor antagonist with Ki of 1.97 nM for hA2B.

More Information Supplier Page

MRS 1754 1mg | ≥98%

CSNpharm

MRS 1754 is a selective adenosine A2B receptor antagonist with Ki of 1.97 nM for hA2B.

More Information Supplier Page

MRS 1754 5mg | ≥98%

CSNpharm

MRS 1754 is a selective adenosine A2B receptor antagonist with Ki of 1.97 nM for hA2B.

More Information Supplier Page

MRS 1754 25mg | ≥98%

CSNpharm

MRS 1754 is a selective adenosine A2B receptor antagonist with Ki of 1.97 nM for hA2B.

More Information Supplier Page

MRS 2578 50mg | ≥98%

CSNpharm

MRS 2578 is a potent and selective P2Y6 nucleotide receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors.

More Information Supplier Page

MRS 2578 10mg | ≥98%

CSNpharm

MRS 2578 is a potent and selective P2Y6 nucleotide receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors.

More Information Supplier Page

MRS 2578 25mg | ≥98%

CSNpharm

MRS 2578 is a potent and selective P2Y6 nucleotide receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors.

More Information Supplier Page

MRT68921 HCl 100mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRT68921 HCl 50mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRT68921 HCl 25mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRT68921 HCl 10mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRT68921 HCl 5mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRT68921 HCl 250mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRT68921 HCl 1mg | ≥99%

CSNpharm

MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM.

More Information Supplier Page

MRX-1024 1g | ≥98%

CSNpharm

MRX-1024 can inhibit the activation of GABAA receptor and exhibit relieving effect on hearing loss. It can used as a chemoprotective agent.

More Information Supplier Page

MS 21570 50mg | ≥98%

CSNpharm

MS 21570 is an antagonist of GPR171 with IC50 of 220 nM.

More Information Supplier Page

MS 21570 100mg | ≥98%

CSNpharm

MS 21570 is an antagonist of GPR171 with IC50 of 220 nM.

More Information Supplier Page

MS 21570 10mg | ≥98%

CSNpharm

MS 21570 is an antagonist of GPR171 with IC50 of 220 nM.

More Information Supplier Page

MS023 10mg | ≥99%

CSNpharm

MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30, 119, 83, 8, and 8 nM for PRMTs 1,3,4,6,and 8, respectively. MS023 is active in cells.

More Information Supplier Page

MS023 50mg | ≥99%

CSNpharm

MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30, 119, 83, 8, and 8 nM for PRMTs 1,3,4,6,and 8, respectively. MS023 is active in cells.

More Information Supplier Page

MS023 100mg | ≥99%

CSNpharm

MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30, 119, 83, 8, and 8 nM for PRMTs 1,3,4,6,and 8, respectively. MS023 is active in cells.

More Information Supplier Page

MS023 25mg | ≥99%

CSNpharm

MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30, 119, 83, 8, and 8 nM for PRMTs 1,3,4,6,and 8, respectively. MS023 is active in cells.

More Information Supplier Page

MS023 5mg | ≥99%

CSNpharm

MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30, 119, 83, 8, and 8 nM for PRMTs 1,3,4,6,and 8, respectively. MS023 is active in cells.

More Information Supplier Page

MS023 2mg | ≥99%

CSNpharm

MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30, 119, 83, 8, and 8 nM for PRMTs 1,3,4,6,and 8, respectively. MS023 is active in cells.

More Information Supplier Page

MS48107 1mg | ≥98%

CSNpharm

MS48107 is a novel positive allosteric modulator of GPR68.

More Information Supplier Page

MS48107 10mg | ≥98%

CSNpharm

MS48107 is a novel positive allosteric modulator of GPR68.

More Information Supplier Page

MS48107 5mg | ≥98%

CSNpharm

MS48107 is a novel positive allosteric modulator of GPR68.

More Information Supplier Page

MSAB 100mg | ≥99%

CSNpharm

MSAB is a selective inhibitor of Wnt/β-catenin signaling. It binds to β-catenin promoting its degradation, and specifically downregulates Wnt/β-catenin target genes.

More Information Supplier Page

MSAB 10mg | ≥99%

CSNpharm

MSAB is a selective inhibitor of Wnt/β-catenin signaling. It binds to β-catenin promoting its degradation, and specifically downregulates Wnt/β-catenin target genes.

More Information Supplier Page

MSAB 50mg | ≥99%

CSNpharm

MSAB is a selective inhibitor of Wnt/β-catenin signaling. It binds to β-catenin promoting its degradation, and specifically downregulates Wnt/β-catenin target genes.

More Information Supplier Page

MSAB 25mg | ≥99%

CSNpharm

MSAB is a selective inhibitor of Wnt/β-catenin signaling. It binds to β-catenin promoting its degradation, and specifically downregulates Wnt/β-catenin target genes.

More Information Supplier Page

MSAB 5mg | ≥99%

CSNpharm

MSAB is a selective inhibitor of Wnt/β-catenin signaling. It binds to β-catenin promoting its degradation, and specifically downregulates Wnt/β-catenin target genes.

More Information Supplier Page

MSC 1094308 5mg | ≥99%

CSNpharm

MSC1094308 is a reversible, allosteric inhibitor of the type II AAA ATPase human ubiquitin-directed unfoldase (VCP)/p97 and the type I AAA ATPase VPS4B.

More Information Supplier Page

MSC 1094308 25mg | ≥99%

CSNpharm

MSC1094308 is a reversible, allosteric inhibitor of the type II AAA ATPase human ubiquitin-directed unfoldase (VCP)/p97 and the type I AAA ATPase VPS4B.

More Information Supplier Page

MSDC-0160 10mg | ≥99%

CSNpharm

MSDC-0160 is a prototype mTOR-modulating insulin sensitizer being studied to treat diabetes and Alzheimer’s disease.

More Information Supplier Page

MSDC-0160 5mg | ≥99%

CSNpharm

MSDC-0160 is a prototype mTOR-modulating insulin sensitizer being studied to treat diabetes and Alzheimer’s disease.

More Information Supplier Page

MSDC-0160 100mg | ≥99%

CSNpharm

MSDC-0160 is a prototype mTOR-modulating insulin sensitizer being studied to treat diabetes and Alzheimer’s disease.

More Information Supplier Page

MSDC-0160 50mg | ≥99%

CSNpharm

MSDC-0160 is a prototype mTOR-modulating insulin sensitizer being studied to treat diabetes and Alzheimer’s disease.

More Information Supplier Page

MSDC-0160 2mg | ≥99%

CSNpharm

MSDC-0160 is a prototype mTOR-modulating insulin sensitizer being studied to treat diabetes and Alzheimer’s disease.

More Information Supplier Page

MSOP 10mg | ≥98%

CSNpharm

MSOP is a selective group III metabotropic glutamate receptor antagonist with apparent KD of 51 μM for the L-AP4-sensitive presynaptic mGluR.

More Information Supplier Page

MSOP 5mg | ≥98%

CSNpharm

MSOP is a selective group III metabotropic glutamate receptor antagonist with apparent KD of 51 μM for the L-AP4-sensitive presynaptic mGluR.

More Information Supplier Page

MSOP 25mg | ≥98%

CSNpharm

MSOP is a selective group III metabotropic glutamate receptor antagonist with apparent KD of 51 μM for the L-AP4-sensitive presynaptic mGluR.

More Information Supplier Page

MSX-127 25mg | ≥99%

CSNpharm

MSX-127 is a potent phosphatase inhibitor.

More Information Supplier Page

MSX-127 5mg | ≥99%

CSNpharm

MSX-127 is a potent phosphatase inhibitor.

More Information Supplier Page

MSX-127 100mg | ≥99%

CSNpharm

MSX-127 is a potent phosphatase inhibitor.

More Information Supplier Page